SIRT1 and type 2 diabetes mellitus: A clinical trial reported that the ingestion of 500 mg RES for 4 weeks resulted in an increase in blood SIRT1 expression as a metabolic regulatory marker in patients with type 2 diabetes mellitus and coronary heart disease [45].